AEVI GENOMIC MEDICINE INC's ticker is GNMX and the CUSIP is 00835P105. A total of 3 filers reported holding AEVI GENOMIC MEDICINE INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $3,000 | 0.0% | 17,213 | 0.0% | 0.00% | – |
| Q3 2019 | $3,000 | 0.0% | 17,213 | 0.0% | 0.00% | – |
| Q2 2019 | $3,000 | 0.0% | 17,213 | 0.0% | 0.00% | – |
| Q1 2019 | $3,000 | -75.0% | 17,213 | 0.0% | 0.00% | – |
| Q4 2018 | $12,000 | -42.9% | 17,213 | 0.0% | 0.00% | – |
| Q3 2018 | $21,000 | -8.7% | 17,213 | -16.0% | 0.00% | – |
| Q2 2018 | $23,000 | -45.2% | 20,500 | 0.0% | 0.00% | – |
| Q1 2018 | $42,000 | +68.0% | 20,500 | 0.0% | 0.00% | – |
| Q4 2017 | $25,000 | -3.8% | 20,500 | 0.0% | 0.00% | – |
| Q3 2017 | $26,000 | -3.7% | 20,500 | 0.0% | 0.00% | – |
| Q2 2017 | $27,000 | -96.0% | 20,500 | -94.3% | 0.00% | – |
| Q1 2017 | $674,000 | -62.3% | 362,475 | +4.9% | 0.00% | – |
| Q4 2016 | $1,789,000 | +7.3% | 345,698 | +15.4% | 0.00% | – |
| Q3 2016 | $1,667,000 | – | 299,549 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 128,000 | $20,000 | 0.01% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 64,390 | $10,000 | 0.00% |
| Verity Asset Management, Inc. | 17,000 | $3,000 | 0.00% |
| VANGUARD GROUP INC | 1,252,050 | $201,000 | 0.00% |
| Kistler-Tiffany Companies, LLC | 690 | $0 | 0.00% |
| BNP PARIBAS FINANCIAL MARKETS | 2 | $0 | 0.00% |
| BARCLAYS PLC | 69 | $0 | 0.00% |
| OneDigital Investment Advisors LLC | 31,110 | $4,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 4,365 | $1,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 15,384 | $2,000 | 0.00% |